342 related articles for article (PubMed ID: 11777181)
1. Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril.
Bensaoula T; Ottlecz A
J Ocul Pharmacol Ther; 2001 Dec; 17(6):573-86. PubMed ID: 11777181
[TBL] [Abstract][Full Text] [Related]
2. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
4. Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats.
Ottlecz A; Garcia CA; Eichberg J; Fox DA
Curr Eye Res; 1993 Dec; 12(12):1111-21. PubMed ID: 8137634
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
6. Captopril inhibits glucose accumulation in retinal cells in diabetes.
Zhang JZ; Gao L; Widness M; Xi X; Kern TS
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):4001-5. PubMed ID: 12939321
[TBL] [Abstract][Full Text] [Related]
7. The effects of captopril and losartan on erythrocyte membrane Na+/K(+)-ATPase activity in experimental diabetes mellitus.
Temel HE; Akyuz F
J Enzyme Inhib Med Chem; 2007 Apr; 22(2):213-7. PubMed ID: 17518348
[TBL] [Abstract][Full Text] [Related]
8. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
Zhang JZ; Xi X; Gao L; Kern TS
Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
[TBL] [Abstract][Full Text] [Related]
9. Identification of angiotensin converting enzyme 2 in the rodent retina.
Tikellis C; Johnston CI; Forbes JM; Burns WC; Thomas MC; Lew RA; Yarski M; Smith AI; Cooper ME
Curr Eye Res; 2004 Dec; 29(6):419-27. PubMed ID: 15764086
[TBL] [Abstract][Full Text] [Related]
10. Increased cytochrome oxidase activity in the diabetic rat retinal pigment epithelium.
Caldwell RB; Slapnick SM
Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):591-9. PubMed ID: 2539341
[TBL] [Abstract][Full Text] [Related]
11. [Renal angiotensin converting enzyme (ACE) expression in diabetic rats: the effect of ACE inhibitors].
Yoshikawa H
Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):486-92. PubMed ID: 10502942
[TBL] [Abstract][Full Text] [Related]
12. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium.
MacGregor LC; Matschinsky FM
Metabolism; 1986 Apr; 35(4 Suppl 1):28-34. PubMed ID: 3007925
[TBL] [Abstract][Full Text] [Related]
13. The effects of elevated glucose on Na+/K(+)-ATPase of cultured bovine retinal pigment epithelial cells measured by a new nonradioactive rubidium uptake assay.
Crider JY; Yorio T; Sharif NA; Griffin BW
J Ocul Pharmacol Ther; 1997 Aug; 13(4):337-52. PubMed ID: 9261769
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats.
Hatcher HC; Ma JX; Chao J; Chao L; Ottlecz A
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):658-64. PubMed ID: 9071220
[TBL] [Abstract][Full Text] [Related]
15. Altered retinal metabolism in diabetes. II. Measurement of sodium-potassium ATPase and total sodium and potassium in individual retinal layers.
MacGregor LC; Matschinsky FM
J Biol Chem; 1986 Mar; 261(9):4052-8. PubMed ID: 3005315
[TBL] [Abstract][Full Text] [Related]
16. Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats.
Nordquist L; Shimada K; Ishii T; Furuya DT; Kamikawa A; Kimura K
Diabetes Metab Res Rev; 2010 Mar; 26(3):193-9. PubMed ID: 20225182
[TBL] [Abstract][Full Text] [Related]
17. Regression of renal hypertrophy and elevated renal Na+,K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats.
Ku DD; Roberts RB; Sellers BM; Meezan E
Endocrinology; 1987 May; 120(5):2166-73. PubMed ID: 3032576
[TBL] [Abstract][Full Text] [Related]
18. Insulin induced translocation of Na+/K+ -ATPase is decreased in the heart of streptozotocin diabetic rats.
Rosta K; Tulassay E; Enzsoly A; Ronai K; Szantho A; Pandics T; Fekete A; Mandl P; Ver A
Acta Pharmacol Sin; 2009 Dec; 30(12):1616-24. PubMed ID: 19915586
[TBL] [Abstract][Full Text] [Related]
19. Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation.
Sun P; Xu N; Li Y; Han Y
Int Immunopharmacol; 2020 Aug; 85():106686. PubMed ID: 32531714
[TBL] [Abstract][Full Text] [Related]
20. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats.
Ku DD; Sellers BM; Meezan E
Endocrinology; 1986 Aug; 119(2):672-9. PubMed ID: 3015553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
